R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the launch of Phare Audit, the most ...
The TARGET (Transforming Antibiotic R&D with Generative AI to stop Emerging Threats) Project is enabling Phare Bio to rapidly scale and optimize its generative AI discovery platform to thwart the ...
MURRAY, Utah, Oct. 22, 2025 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the launch of the Phare Operating System, healthcare’s first ...
Phare Bio has been awarded $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The biotech startup will use the money to advance its antibiotic discovery initiative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results